|
IDE397 Clinical Trials
2 actively recruiting trials across 2 locations
Scottsdale, Arizona1 trial
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Honor Health Research Institute
Phase 1
Houston, Texas1 trial
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
NEXT Oncology Houston
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.